304 related articles for article (PubMed ID: 14528079)
1. Tumor dimension and prognosis in surgically treated lung cancer: for intentional limited resection.
Nonaka M; Kadokura M; Yamamoto S; Kataoka D; Kunimura T; Kushima M; Horichi N; Takaba T
Am J Clin Oncol; 2003 Oct; 26(5):499-503. PubMed ID: 14528079
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
3. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):87-93. PubMed ID: 15632829
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
6. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
Ma K; Wang TY; He BL; Chang D; Gong M
Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
Christian C; Erica S; Morandi U
Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
9. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
10. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of pathological stage III and IV in non-small cell lung cancer with peripheral tumor of 3 cm or less in diameter].
Kikuchi K; Kase K; Sensaki K; Masuda H; Takagi K; Ogata T; Tanaka S
Kyobu Geka; 1991 Jan; 44(1):51-5. PubMed ID: 1645421
[TBL] [Abstract][Full Text] [Related]
12. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.
Shimizu K; Yoshida J; Nagai K; Nishimura M; Yokose T; Ishii G; Nishiwaki Y
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1574-8. PubMed ID: 15173709
[TBL] [Abstract][Full Text] [Related]
13. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
[TBL] [Abstract][Full Text] [Related]
14. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
15. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
17. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
[TBL] [Abstract][Full Text] [Related]
18. Tumor size and extension of lymph node metastases in N2 lung cancer.
Watanabe Y; Murakami S; Oda M; Ohta Y; Watanabe S; Nozawa H; Kamesui T; Nozaki Y; Nonomura A; Minato H; Kitagawa M
Ann Ital Chir; 1999; 70(6):889-92. PubMed ID: 10804667
[TBL] [Abstract][Full Text] [Related]
19. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
